Gapping up
In reaction to strong earnings/guidance:
- GNC +5.9%, DVA +5.4%, PHG +4.6%, SALT +1.9%, HAL +1.8%, RPM +1.7%, BOH +0.6%
M&A news:
- SKIS +112.7% ( to be acquired by Vail Resorts (MTN) for $11.00/share in cash)
- CDOR +32.6% (to be acquired by NexPoint Hospitality Trust for $11.10 per share)
Select metals/mining stocks trading higher:
- MT +3.2%, CDE +1.9%, NUE +1.7%, FSM +1.6%, SLV +1.3%, FMS +1.2%, SBGL +1%, AUY +0.9%, AG +0.9%, BHP +0.7%
Other news:
- ACHN +2.9% (announces 'positive' results from their Phase 1 multiple ascending dose (MAD) study with ACH-5228 outside of the US)
- BG +2.6% (Bunge, BP plc (BP) to form 50:50 joint venture that will create a leading bioenergy company in Brazil)
- CTST +2.2% (provides interim update on investigation being undertaken by special committee)
- XXII +1% (announces the FDA accepted and filed for substantive scientific review Modified Risk Tobacco Product application for exclusive Very Low Nicotine Content cigarettes under VLN brand)
- DIS +0.8% (Postive view in Barrons)
- AZN +0.8% (FDA has approved the inclusion of overall survival (OS) data from the Phase III PACIFIC trial in an update to the IMFINZI)
Analyst comments:
- AMRX +4.7% (upgraded to Outperform from Mkt Perform at SVB Leerink)
- SFIX +3.3% (upgraded to Buy from Hold at Stifel)
- MU +2.7% (upgraded to Buy from Neutral at Goldman)
- LRCX +2.5% (upgraded to Buy from Neutral at Goldman)
- AMAT +2.3% (upgraded to Buy from Neutral at Goldman and added to Conviction Buy List)
- CAL +2.2% (upgraded to Positive from Neutral at Susquehanna)
- KLAC +1.6% (upgraded to Neutral from Sell at Goldman)
- NEWM +1.5% (upgraded to Buy from Neutral at Citigroup)
- SCHW +1.3% (upgraded to Outperform from Market Perform at Wells Fargo)